Sustained Response Following Discontinuation of Methotrexate in Patients with Rheumatoid Arthritis Treated with Subcutaneous Tocilizumab
Arthritis Rheumatol 2018;70:1200–08 DOI 10.1002/art.40493
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Arthritis Rheumatol 2018;70:1200–08 DOI 10.1002/art.40493
ADV Ther 2018; 35(10):1525–63 DOI: 10.1007/s12325-018-0757-2
Ann Rheum Dis 2018; 77:1268–1275 DOI: 10.1093/rheumatology/key121
Rheumatology 2018;57:1423–1431 DOI: 10.1093/rheumatology/key121
Exp Rev Clin Immunol 2018 Nov;14(11):945-956. DOI: 10.1080/1744666X.2018.1504678
Drug Safety 2018 Jul;41(7):645–53
Lancet 2018;391:2513–24
RMD Open. 2018 May 8;4(1):e000662. DOI: 10.1136/rmdopen-2018-000662
Rheumatol Ther. 2018 Dec;5(2):341-353. doi: 10.1007/s40744-018-0113-7